MYOV: Myovant Sciences Ltd. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 2,605.87
Enterprise Value ($M) 2,713.98
Book Value ($M) -558.14
Book Value / Share -5.76
Price / Book -4.67
NCAV ($M) -575.08
NCAV / Share -5.93
Price / NCAV -4.53

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.30
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 1.45
Current Ratio 1.57

Balance Sheet (mrq) ($M)
Current Assets 386.59
Assets 403.52
Liabilities 961.66
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
10-24 13D/A Sumitomo Chemical Co., Ltd. 51.70 0.00
02-11 13G/A Bb Biotech Ag 6.60 28.69
02-10 13G/A Janus Henderson Group Plc 5.90 8.42
02-04 13G Wellington Management Group Llp 6.50

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2023-01-26 10-Q Table of Contents
2022-10-26 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One)
2022-07-27 10-Q Table of Contents
2022-05-11 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2023-01-27 21,777 483,009 4.51
2023-01-26 14,586 244,911 5.96
2023-01-25 23,317 294,361 7.92
2023-01-24 35,831 378,969 9.45
2023-01-23 57,258 591,772 9.68

(click for more detail)

Similar Companies
LCI – Lannett Company, Inc. LLY – Eli Lilly And Co
MRK – Merck & Co., Inc. NUVB – Nuvation Bio Inc
NVO – Novo-Nordisk A/S


Financial data and stock pages provided by
Fintel.io